These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2664820)

  • 1. Some aspects of controlled release dosage forms.
    Rachev D; Lambov N; Minkov E
    Pharmazie; 1989 Mar; 44(3):186-9. PubMed ID: 2664820
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relation between the structure of polymers and the controlled release of active ingredients].
    Peppas NA; Gurny R
    Pharm Acta Helv; 1983; 58(1):2-8. PubMed ID: 6338530
    [No Abstract]   [Full Text] [Related]  

  • 3. [Application and theoretical development of pharmaceutical forms for controlled liberation using methacrylic films. Preliminary communication. Fabrication and evaluation of free film plans].
    Gurny R; Mordier D; Buri P
    Pharm Acta Helv; 1976; 51(12):384-90. PubMed ID: 1023228
    [No Abstract]   [Full Text] [Related]  

  • 4. Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms.
    Skelley JP; Amidon GL; Barr WH; Benet LZ; Carter JE; Robinson JR; Shah VP; Yacobi A
    J Pharm Sci; 1990 Sep; 79(9):849-54. PubMed ID: 1980308
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ways and means for prolonging the action of drugs (the status of the problem and the outlook)].
    Golikov SN; Gur'ianov GA; Kozlov VK
    Farmakol Toksikol; 1989; 52(2):5-15. PubMed ID: 2663542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysalt flocculates as a physicochemical approach in the development of controlled-release oral pharmaceuticals.
    Salib NN; El-Menshawy ME; Ismail AA
    Pharmazie; 1976; 31(12):872-4. PubMed ID: 1023265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate-controlled drug dosage.
    Urquhart J
    Drugs; 1982 Mar; 23(3):207-26. PubMed ID: 7042294
    [No Abstract]   [Full Text] [Related]  

  • 8. Calculation of the dimensions of drug-polymer devices based on diffusion parameters.
    Siepmann J; Ainaoui A; Vergnaud JM; Bodmeier R
    J Pharm Sci; 1998 Jul; 87(7):827-32. PubMed ID: 9649350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Formal requirements and a cultural approach to the control of slow-release dosage forms].
    Ciranni Signoretti E
    Boll Chim Farm; 1989 Jun; 128(6):199-201. PubMed ID: 2619987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellulose hydrogen phthalate. A coating polymer in controlled release dosage forms.
    Dor P; Benita S; Levesque G
    Pharm Acta Helv; 1987; 62(9):255-61. PubMed ID: 3423094
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of formulation on drug action.
    Münzel K
    Pharm Acta Helv; 1971 Sep; 46(9):513-38. PubMed ID: 5099398
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fluoridated amalgams].
    Horálek P
    Prakt Zubn Lek; 1986 Mar; 34(2):52-5. PubMed ID: 3460058
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study on index for formulation optimization of sustained or controlled released dosage forms].
    Hong YL; Feng Y; Xu DS
    Zhongguo Zhong Yao Za Zhi; 2006 Jan; 31(1):15-7. PubMed ID: 16548158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical design and development of a Sinemet controlled-release formulation.
    Dempski RE; Scholtz EC; Oberholtzer ER; Yeh KC
    Neurology; 1989 Nov; 39(11 Suppl 2):20-4. PubMed ID: 2685648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microencapsulation.
    Sliwka W
    Angew Chem Int Ed Engl; 1975 Aug; 14(8):539-50. PubMed ID: 810049
    [No Abstract]   [Full Text] [Related]  

  • 17. Scleroglucan sustained release oral preparations. Part II. Effects of additives.
    Alhaique F; Beltrami E; Riccieri FM; Santucci E; Touitou E
    Drug Des Deliv; 1990 Mar; 5(3):249-57. PubMed ID: 1670505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and experimental evaluation of oral sustained release medication based on the principle of delayed diffusion.
    SIMOONS JR
    Pharm Weekbl; 1963 Mar; 98():225-42. PubMed ID: 13977548
    [No Abstract]   [Full Text] [Related]  

  • 19. Rosin and rosin derivatives as hydrophobic matrix materials for controlled release of drugs.
    Pathak YV; Dorle AK
    Drug Des Deliv; 1990 Sep; 6(3):223-7. PubMed ID: 2076181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physicochemical involvement in pharmacokinetic processes].
    Botrè C; Guidotti M
    Boll Chim Farm; 1978 Apr; 117(4):189-216. PubMed ID: 743369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.